帝科股份(300842.SZ)擬12.47億元收購江蘇索特100%股權 攬入原杜邦集團旗下Solamet®光伏銀漿業務
格隆匯12月31日丨帝科股份(300842.SZ)公佈,公司以發行股份的方式購買江蘇索特電子材料有限公司(簡稱“江蘇索特”)100%股權,交易對價為12.47億元;同時擬向不超過35名符合條件的特定對象發行股份募集配套資金。該次交易完成後,公司將持有江蘇索特100%的股權,並通過江蘇索特擁有原杜邦集團旗下的Solamet®光伏銀漿業務。
江蘇索特旗下的Solamet®光伏銀漿業務深耕電子漿料行業三十餘載,不斷致力於引領光伏導電漿料的技術創新,是光伏導電漿料領域的開創先驅與技術引領者,在玻璃、銀粉、有機體三大體系均形成了具備較強市場競爭力的核心技術,並積極將科研成果及核心技術轉化為專利進行保護和應用,具備全面的專利佈局。
該次交易不會導致上市公司實際控制人發生變更。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.